I do believe that we will hear news on revenues, I really can't imagine that the CFO would let them engage in more acquisitions without some kind of revenues being harvested.
I also would like to know how many calls will be taken, if any and press them on Lympo or any other spin offs.
When is that 12 week FDA news coming out?